L9: Good clinical practice Flashcards

1
Q

what does GCP stand for?

A

good clinical practice. the international ethical and scientific quality standard for designing, conducting and reporting clinical trials that involve human subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GCP only covers phase IV clinical trials. T/F?

A

False. it covers phase I-IV clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

main focus of GCP [3]

A
  1. protect human rights in clinical trial
  2. provide assurance of safety of newly developed pdt
  3. define role and responsibilities of people involved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why was the US Food drugs and cosmetic act enacted?

A

there were dangerous over the counter drugs sold eg. Grandma’s secret.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what change did the US Food drugs and cosmetic act 1938 bring about?

A

Change: manufacturers are required to do t test for safety and report to FDA before marketing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how did the Nuremberg Code 1947 come about?

A

a group of german physicians experimented on WW2 prisoners in nazi camps–> highlighted how there is a need for scientific basis for research on human subjects + volunteer consent and protection of human subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

key points from the Nuremberg Code [4]

A
  1. require voluntary, well-informed understanding consent of human subject
  2. should aim at +ve results and based on previous knowledge that justifies expt
  3. need to avoid unnecessary physical and mental suffering of subjects
  4. human subjects must be free to quit expt at any point OR medical staff to stop expt if they observe that continuing is dangerous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

who created Declaration of Helsinki?

A

world medical association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is Declaration of Helsinki created for?

A
  • started when limb deformities observed from maternal thalidomide use
    create ethical principles to guide physicians and participants in research
  • informed consent/respect, risk-benefit assessment, selection of subjects of research
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what did the Tuskegee Syphilis expt highlight? [3]

A

the need to uphold ethics, justice and respect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 main aspects of Belmont Report

A
  1. Respect for persons: protect person’s dignity and freedom/autonomy ==> NEED CONSENT
  2. Beneficence: researchers should MAXIMISE BENEFITS and minimise harm
  3. Justice: equitable selection and recruitment and fair treatment of human subjects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what did the International Guidelines for Biomedical research involving human research bring about?

A

WHO and CIOMS helped developing countries apply the Nuremberg Code and Declaration of Helsinki

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does ICH GCP stand for?

A

International Conference on Harmonisation’s (ICH) Guideline for good clinical practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does ICH GCP aim to do?

A

overcome inconsistencies in GCP internationally. streamline data used by countries eg. if country A conduct trial according to ICH GCP, country B will be able to use data from that trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

state the 13 principles of GCP

A

Ethics [3]
1. follow ethical principles that originate from Declaration of Helsinki and that of GCP and applicable regulatory requirements
2. before trial starts, need to weigh risk and inconveniences against benefits [must justify benefits over risks]
3. MUST consider rights, safety and well-being of human
subject

Protocol and science [2]:
4. need to support trial w clinical and non-clinical info
5. clinical trials shld be clinically sound and described in clear detailed protocol

Responsibilities:[3]
6. comply with protocol received prior to MCRC an hospital EC approval
7. only qualified physicians are responsible for medical care and decisions of subjects
8. person conducting trial MUST BE QUALIFIED by education, training and experience

INformed consent [1]: subject need to give consent

Data quality and integrity of trial [2]: all trial info must be recorded/handled/interpreted accurately + CONFIDENTIALITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

13 Principles of GCP: ethics [3]

A
  1. follow ethical principles that originate from Declaration of Helsinki and that of GCP and applicable regulatory requirements
  2. before trial starts, need to weigh risk and inconveniences against benefits [must justify benefits over risks]
  3. MUST consider rights, safety and well-being of human
    subject
17
Q

13 principles of GCP: Protocol and science [2]

A
  1. need to support trial w clinical and non-clinical info
  2. clinical trials shld be clinically sound and described in clear detailed protocol
18
Q

principles of GCP: responsibilities [3]

A
  1. comply with protocol received prior to MCRC an hospital EC approval
  2. only qualified physicians are responsible for medical care and decisions of subjects
  3. person conducting trial MUST BE QUALIFIED by education, training and experience
19
Q

Principles of GCP: data quality and integrity [2]

A

Data quality and integrity of trial [2]:
-all trial info must be recorded/handled/interpreted accurately
- CONFIDENTIALITY

20
Q

principles of GCP: investigational pdts [1]

A

pdts should be manufactured, handled and stored accordance with applicable GMP

21
Q

principles of GCP: quality control/assurance [1]

A

need to implement systems with procedures that assure the quality of EVERY ASPECT of trial

22
Q

key issues with investigational product [3]

A

-LEAD creation
- must be GMP
- have pre-clinical testing

23
Q

key issues faced by investigator

A
  • conduct trial based on Helsinki and ICP
  • need to apply for approval
24
Q

key issues faced by regulators [state regulators in SG]

A

review ethics [IRB & MOH]

25
Q

issues faced by participants

A

informed consent

26
Q

key issues faced by sponsors

A

need to prepare trial protocol [objective, design, methods, stats considerations and organisation]